{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:38:37Z","timestamp":1793306317103,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 183707"],"award-info":[{"award-number":["FRN 183707"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.10.031","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:47:34Z","timestamp":1762829254000},"page":"985-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal adherence thresholds for oral anticoagulants in patients with atrial fibrillation using machine learning and population administrative data"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9715-3086","authenticated-orcid":false,"given":"Abdollah","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7739-1407","authenticated-orcid":false,"given":"Hamed","family":"Helisaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-6129","authenticated-orcid":false,"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8434-7076","authenticated-orcid":false,"given":"Marc W.","family":"Deyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-3388","authenticated-orcid":false,"given":"Shahrzad","family":"Salmasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-2392","authenticated-orcid":false,"given":"Adenike","family":"Adelakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-0088","authenticated-orcid":false,"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-2683","authenticated-orcid":false,"given":"Mary A.","family":"De Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-6438","authenticated-orcid":false,"given":"Peter","family":"Loewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.10.031_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034778","article-title":"Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"10","author":"Salmasi","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2025.10.031_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2025.10.031_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.10.031_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/joa3.12656","article-title":"Adherence with direct oral anticoagulants in patients with atrial fibrillation: trends, risk factors, and outcomes","volume":"38","author":"Arbel","year":"2022","journal-title":"J Arrhythm"},{"key":"10.1016\/j.jtha.2025.10.031_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jjcc.2022.09.009","article-title":"Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: insights from MISOAC-AF trial","volume":"81","author":"Patsiou","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2016.03.212","article-title":"Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke","volume":"215","author":"Alberts","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12872-017-0671-6","article-title":"Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the Veterans Health Administration","volume":"17","author":"Borne","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jtha.2025.10.031_bib8","doi-asserted-by":"crossref","first-page":"f72","DOI":"10.1093\/ehjcvp\/pvaa017","article-title":"Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk","volume":"7","author":"Komen","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jtha.2025.10.031_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/healthcare9101313","article-title":"Association between cerebral infarction risk and medication adherence in atrial fibrillation patients taking direct oral anticoagulants","volume":"9","author":"Akagi","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jtha.2025.10.031_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035639","article-title":"Association between oral anticoagulant adherence and serious clinical outcomes in patients with atrial fibrillation: a long-term retrospective cohort study","volume":"13","author":"Safari","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.10.031_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jac5.1771","article-title":"Research and scholarly methods: measuring medication adherence","volume":"6","author":"Shah","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.jtha.2025.10.031_bib12","first-page":"78","article-title":"Medication adherence as a measure of the quality of care provided by physicians","volume":"25","author":"Seabury","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jtha.2025.10.031_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.HYP.2.6.757","article-title":"Can simple clinical measurements detect patient noncompliance?","volume":"2","author":"Haynes","year":"1980","journal-title":"Hypertension"},{"key":"10.1016\/j.jtha.2025.10.031_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2025.10.031_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pds.5242","article-title":"Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: a surveillance study","volume":"30","author":"Zielinski","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2025.10.031_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ehjcvp\/pvw048","article-title":"Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists","volume":"3","author":"S\u00f8rensen","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jtha.2025.10.031_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11239-023-02921-8","article-title":"Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study","volume":"57","author":"Salmasi","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.10.031_bib18","doi-asserted-by":"crossref","first-page":"A42","DOI":"10.1093\/eurheartj\/suab152","article-title":"Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation","volume":"24","author":"Farinha","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jtha.2025.10.031_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10557-023-07507-3","article-title":"Minimal adherence threshold to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation to reduce the risk of thromboembolism and death: a nationwide cohort study","volume":"39","author":"Grymonprez","year":"2025","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jtha.2025.10.031_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/europace\/euz273","article-title":"The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients","volume":"22","author":"Kim","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jtha.2025.10.031_bib21","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2147\/PPA.S324315","article-title":"Estimated thresholds of minimum necessary adherence for effective treatment with direct oral anticoagulants\u2014a retrospective cohort study in health insurance claims data","volume":"15","author":"Wirbka","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jtha.2025.10.031_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40268-017-0216-6","article-title":"The adherence rate threshold is drug specific","volume":"17","author":"Stauffer","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.jtha.2025.10.031_bib23","first-page":"1133","article-title":"Population Data BC: supporting population data science in British Columbia","volume":"4","author":"Ark","year":"2019","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.jtha.2025.10.031_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"Plos Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib26","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.10.031_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2025.10.031_bib28","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1111\/bcp.15391","article-title":"Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: a scoping review and new tool TEN\u2013SPIDERS","volume":"88","author":"Dalli","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2025.10.031_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1524-4733.2009.00543.x","article-title":"Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia","volume":"12","author":"Karve","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jtha.2025.10.031_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40545-021-00385-w","article-title":"Estimating proportion of days covered (PDC) using real-world online medicine suppliers\u2019 datasets","volume":"14","author":"Prieto-Merino","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.jtha.2025.10.031_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/aje\/kwab295","article-title":"The Random Effects Warfarin Days\u2019 Supply (REWarDS) model: development and validation of a novel method to estimate exposure to warfarin using administrative data","volume":"191","author":"Salmasi","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib32","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2021.09.1370","article-title":"Longitudinal oral anticoagulant adherence trajectories in patients with atrial fibrillation","volume":"78","author":"Salmasi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.10.031_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamainternmed.2021.1197","article-title":"Adverse events associated with the addition of aspirin to direct oral anticoagulant therapy without a clear indication","volume":"181","author":"Schaefer","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jtha.2025.10.031_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12913-020-05999-5","article-title":"Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data","volume":"21","author":"Sharma","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jtha.2025.10.031_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jtha.2025.10.031_bib39","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jtha.2025.10.031_bib40","unstructured":"Safari A, Helisaz H, Loewen P. biniLasso: automated cut-point detection via sparse cumulative binarization. arXiv 2025:2503.16687v2. https:\/\/doi.org\/10.1111\/j.1541-0420.2005.00454.x"},{"key":"10.1016\/j.jtha.2025.10.031_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jtha.2025.10.031_bib42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib43","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.jtha.2025.10.031_bib44","series-title":"Generalized additive models","author":"Hastie","year":"2017"},{"key":"10.1016\/j.jtha.2025.10.031_bib45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pds.4334","article-title":"The myths of medication adherence","volume":"26","author":"Gellad","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2025.10.031_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2025.10.031_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12876-020-01219-w","article-title":"Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes","volume":"20","author":"Allard","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jtha.2025.10.031_bib48","first-page":"719","article-title":"Using pharmacy data and adherence to define long-term bisphosphonate exposure in women","volume":"25","author":"Izano","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jtha.2025.10.031_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAI.0000000000000643","article-title":"Adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy","volume":"69","author":"Viswanathan","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jtha.2025.10.031_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223062","article-title":"Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: a cohort study","volume":"14","author":"Zongo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.10.031_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ajg.2017.438","article-title":"Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases","volume":"113","author":"Govani","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2025.10.031_bib52","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fphar.2018.01540","article-title":"Is There a threshold for medication adherence? Lessons learnt from electronic monitoring of drug adherence","volume":"9","author":"Burnier","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2025.10.031_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40263-020-00713-9","article-title":"Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis","volume":"34","author":"Yaegashi","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jtha.2025.10.031_bib55","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jval.2019.06.009","article-title":"Impact of star rating medication adherence measures on adherence for targeted and nontargeted medications","volume":"22","author":"Parekh","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jtha.2025.10.031_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2008.10.001","article-title":"Defining an evidence-based cutpoint for medication adherence in heart failure","volume":"157","author":"Wu","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2025.10.031_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003088-198611060-00005","article-title":"Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship","volume":"11","author":"Holford","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtha.2025.10.031_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajem.2016.09.046","article-title":"Bleeding with direct oral anticoagulants vs warfarin: clinical experience","volume":"34","author":"Eikelboom","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib59","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11096-022-01386-8","article-title":"Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review","volume":"44","author":"Fahmi","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jtha.2025.10.031_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100131","article-title":"Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding","volume":"7","author":"Kang","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.031_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021601","article-title":"Long-term medication adherence trajectories to direct oral anticoagulants and clinical outcomes in patients with atrial fibrillation","volume":"10","author":"An","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.10.031_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ehjqcco\/qcac023","article-title":"Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study","volume":"9","author":"Lee","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jtha.2025.10.031_bib63","first-page":"1219","article-title":"Trajectories of adherence to extended treatment with direct oral anticoagulants and risks of recurrent venous thromboembolism and major bleeding","volume":"29","author":"Kang","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jtha.2025.10.031_bib64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/03007995.2018.1530205","article-title":"Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients","volume":"35","author":"McHorney","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jtha.2025.10.031_bib65","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fphar.2018.01353","article-title":"Estimating adherence based on prescription or dispensation information: impact on thresholds and outcomes. a real-world study with atrial fibrillation patients treated with oral anticoagulants in Spain","volume":"9","author":"Hurtado-Navarro","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2025.10.031_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2023.06.086","article-title":"Comprehension of nonvalvular atrial fibrillation and anticoagulant adherence in elderly patients in a subcohort study of the All Nippon Atrial Fibrillation in the Elderly Registry","volume":"204","author":"Akao","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2021.03.024","article-title":"Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY Trial)","volume":"149","author":"Millenaar","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.10.031_bib68","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib70","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jtha.2025.10.031_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.jtha.2025.10.031_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019002364","article-title":"Long-term treatment of venous thromboembolism","volume":"135","author":"Kearon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.031_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15420\/ecr.2017:11:2","article-title":"Direct oral anticoagulants: a quick guide","volume":"12","author":"Julia","year":"2017","journal-title":"Eur Cardiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:04:35Z","timestamp":1781453075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625008323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538783625008323"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.031","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal adherence thresholds for oral anticoagulants in patients with atrial fibrillation using machine learning and population administrative data","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}